In vivo animal models of cerebral vasospasm: A review

Neurosurgery

Volumn 46, Issue 2, 2000, Pages 448-461

  Megyesi, Joseph F ^a   Vollrath, Bozena ^a   Cook, David A ^a   Findlay, J Max ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b University Campus   (Canada)

Author keywords

Animal model; Cerebral vasospasm; Review; Subarachnoid hemorrhage

Indexed keywords

ANIMAL MODEL; BASILAR ARTERY; BLOOD AUTOTRANSFUSION; BLOOD CLOT; BRAIN ARTERY; BRAIN ARTERY ANEURYSM; BRAIN VASOSPASM; CISTERNA MAGNA; DISEASE SIMULATION; NONHUMAN; PRIORITY JOURNAL; PUNCTURE; REVIEW; SUBARACHNOID HEMORRHAGE;

EID: 0033965561     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-200002000-00035     Document Type: Review

References (141)

1. Afshar JK, Pluta RM, Boock RJ, Thompson BG, Oldfield EH: Effect of intracarotid nitric oxide on primate cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 83:118-122, 1995.
2. Alexander E III, Black PMcL, Liszczak TM, Zervas NT: Delayed CSF lavage for arteriographic and morphological vasospasm after experimental SAH. J Neurosurg 63:949-958, 1985.
3. Allcock JM: Arterial spasm in subarachnoid haemorrhage: A clinical and experimental study. Acta Radiol Diagn (Stockh) 5:73-82, 1966.
4. Allen GS, Henderson LM, Chou SN, French LA: Cerebral arterial spasm: Part I - In vitro contractile activity of vasoactive agents on canine basilar and middle cerebral arteries. J Neurosurg 40:433-441, 1974.
5. Awad IA, Little JR: A rat femoral artery model for vasospasm. Neurosurgery 27:356, 1990 (comment).
6. Bagley C Jr: Blood in the cerebrospinal fluid: Resultant functional and organic alterations in the central nervous system -Part A: Experimental data. Arch Surg 17:18-38, 1928.
7. Baker KF, Zervas NT, Pile-Spellman J, Vacanti FX, Miller D: Angiographic evidence of basilar artery constriction in the rabbit: A new model of vasospasm. Surg Neurol 27:107-112, 1987.
8. Barry KJ, Gogjian MA, Stein BM: Small animal model for investigation of subarachnoid hemorrhage and cerebral vasospasm. Stroke 10:538-541, 1979.
9. Bederson JB, Germano IM, Guarino L: Cortical blood flow and cerebral perfusion pressure in a new noncraniotomy model of subarachnoid hemorrhage in the rat. Stroke 26:1086-1092, 1995.
10. Boisvert DP, Pickard JD, Graham DI, Fitch W: Delayed effects of subarachnoid haemorrhage on cerebral metabolism and the cerebrovascular response to hypercapnia in the primate. J Neurol Neurosurg Psychiatry 42:892-898, 1979.
11. Boullin DJ: Assessment of animal models, in Wilkins RH (ed): Cerebral Arterial Spasm: Proceedings of the Second International Workshop. Baltimore, Williams & Wilkins, 1980, pp 291-293.
12. Boullin DJ, Hunt TM, Rogers AT: Models for investigating the aetiology of cerebral arterial spasm: Comparative responses of the human basilar artery with rat colon, anococcygeus, stomach fundus, and aorta and guinea-pig ileum and colon. Br J Pharmacol 63:251-257, 1978.
13. Brawley BW, Strandness DE Jr: Continuous recordings of the intracranial internal carotid artery size in the dog. J Surg Res 7:250-253, 1967.
14. Brawley BW, Strandness DE Jr, Kelly WA: The biphasic response of cerebral vasospasm in experimental subarachnoid hemorrhage. J Neurosurg 28:1-8, 1967.
15. Chan RC, Durity FA, Thompson GB, Nugent RA, Kendall M: The role of the prostacyclin-thromboxane system in cerebral vasospasm following induced subarachnoid hemorrhage in the rabbit. J Neurosurg 61:1120-1128, 1984.
16. Chan PD, Findlay JM, Vollrath B, Cook DA, Grace M, Chen MH, Ashforth RA: Pharmacological and morphological effects of in vitro transluminal balloon angioplasty on normal and vasospastic canine basilar arteries. J Neurosurg 83:522-530, 1995.
17. Chow RW, Newton TH, Smith MC, Adams JE: Cerebral vasospasm induced by subarachnoid blood and serotonin: An angiographic study. Invest Radiol 3:402-407, 1968.
18. Clower BR, Smith RR, Haining JL, Lockard J: Constrictive endarteropathy following experimental subarachnoid hemorrhage. Stroke 12:501-508, 1981.
19. Cohen C: The case for the use of animals in biomedical research. N Engl J Med 315:865-870, 1986.
20. Conway LW, McDonald LW: Structural changes of the intra-dural arteries following subarachnoid hemorrhage. J Neurosurg 37:715-723, 1972.
21. Crompton MR: The pathogenesis of cerebral infarction following the rupture of cerebral berry aneurysms. Brain 87:491-510, 1964.
22. Dahl E: Microscopic observations on cerebral arteries, in Cervos-Navarro J (ed): The Cerebral Wall. New York, Raven Press, 1976, pp 15-21.
23. Delgado TJ, Brismar J, Svendgaard NA: Subarachnoid haemorrhage in the rat: Angiography and fluorescence microscopy of the major cerebral arteries. Stroke 16:595-602, 1985.
24. Delgado-Zygmunt TJ, Arbab MA, Shiokawa Y, Svendgaard NA: A primate model for acute and late cerebral vasospasm: Angiographic findings. Acta Neurochir (Wien) 118:130-136, 1992.
25. Duff TA, Louie J, Feilbach JA, Scott G: Erythrocytes are essential for development of cerebral vasculopathy resulting from subarachnoid hemorrhage in cats. Stroke 19:68-72, 1988.
26. Echlin FA: Spasm of basilar and vertebral arteries caused by experimental subarachnoid hemorrhage. J Neurosurg 23:1-11, 1965.
27. Echlin F: Experimental vasospasm, acute and chronic, due to blood in the subarachnoid space. J Neurosurg 35:646-656, 1971.
28. Edvinsson L: The blood vessel wall: Endothelial and smooth muscle cells, in Edvinsson L (ed): Cerebral Blood Flow and Metabolism. New York, Raven Press, 1993, pp 40-56.
29. Edvinsson L, Egund N, Owman C, Sahlin C, Svendgaard NA: Reduced noradrenaline uptake and retention in cerebrovascular nerves associated with angiographically visible vasoconstriction following experimental subarachnoid hemorrhage in rabbits. Brain Res Bull 9:799-805, 1982.
30. Egemen N, Sanlidilek U, Zorlutuna A, Baskaya M, Bilgic S, Caglar S, Unlu A: Transclival approach to rabbit basilar artery for experimental induction of chronic vasospasm. Acta Neurochir (Wien) 115:123-126, 1992.
31. Eldevik OP, Kristiansen K, Torvik A: Subarachnoid hemorrhage and cerebrovascular spasm: Morphological study of intracranial arteries based on animal experiments and human autopsies. J Neurosurg 55:869-876, 1981.
32. Endo S, Branson PJ, Alksne JF: Experimental model of symptomatic vasospasm in rabbits. Stroke 19:1420-1425, 1988.
33. Espinosa F, Weir B, Boisvert D, Overton T, Castor W: Chronic cerebral vasospasm after large subarachnoid hemorrhage in monkeys. J Neurosurg 57:224-232, 1982.
34. Espinosa F, Weir B, Overton T, Castor W, Grace M, Boisvert D: A randomized placebo-controlled double-blind trial of nimodipine after SAH in monkeys: Part I - Clinical and radiological findings. J Neurosurg 60:1167-1175, 1984.
35. Espinosa F, Weir B, Shnitka T: Electron microscopy of simian cerebral arteries after subarachnoid hemorrhage and after the injection of horseradish peroxidase. Neurosurgery 19:935-945, 1986.
36. Fadel MM, Foley PL, Kassell NF, Lee KS: Histidine attenuates cerebral vasospasm in a rabbit model of subarachnoid hemorrhage. Surg Neurol 43:52-58, 1995.
37. Farrar JK: Chronic cerebral arterial spasm: The role of intracranial pressure. J Neurosurg 43:408-417, 1975.
38. Findlay JM, Kassell NF, Weir BK, Haley EC Jr, Kongable G, Germanson T, Truskowski L, Alves WM, Holness RO, Knuckey NW, Yonas H, Steinberg GK, West M, Winn HR, Ferguson G: A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm. Neurosurgery 37:168-178, 1995.
39. Findlay JM, Weir BK, Kanamaru K, Espinosa F: Arterial wall changes in cerebral vasospasm. Neurosurgery 25:736-746, 1989.
40. Findlay JM, Weir BK, Steinke D, Tanabe T, Gordon P, Grace M: Effect of intrathecal thrombolytic therapy on subarachnoid clot and chronic vasospasm in a primate model of SAH. J Neurosurg 69:723-735, 1988.
41. Fisher CM, Kistler JP, Davis JM: Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6:1-9, 1980.
42. Fitch W, Pickard JD, Tamura A, Graham DI: Effects of hypotension induced with sodium nitroprusside on the cerebral circulation before, and one week after, the subarachnoid injection of blood. J Neurol Neurosurg Psychiatry 51:88-93, 1988.
43. Fraser RA: Cerebral vasospasm: After 15 years in the laboratory, in Wilkins RH (ed): Cerebral Arterial Spasm: Proceedings of the Second International Workshop, Amsterdam, the Netherlands, 1979. Baltimore, Williams & Wilkins, 1980, pp 287-290.
44. Fraser RA, Stein BM, Barrett RE, Pool JL: Noradrenergic mediation of experimental cerebrovascular spasm. Stroke 1:356-362, 1970.
45. Frazee JG: A primate model of chronic cerebral vasospasm. Stroke 13:612-614, 1982.
46. Fujii Y, Takahashi A, Yoshimoto T: Percutaneous transluminal angioplasty in a canine model of cerebral vasospasm: Angiographic, histologic, and pharmacologic evaluation. Surg Neurol 44:163-171, 1995.
47. Fukuroda T, Nishikibe M, Ohta Y, Ihara M, Yano M, Ishikawa K, Fukami T, Ikemoto F: Analysis of responses to endothelins in isolated porcine blood vessels by using a novel endothelin antagonist, BQ-153. Life Sci 50:PL107-112, 1992.
48. Harada T, Seto M, Sasaki Y, London S, Luo Z, Mayberg M: The time course of myosin light-chain phosphorylation in blood-induced vasospasm. Neurosurgery 36:1178-1183, 1995.
49. Hassler O: Morphological studies on the large cerebral arteries, with reference to the etiology of subarachnoid hemorrhage. Acta Psychiatr Neurol Scand Suppl 154:1-145, 1961.
50. Hayakawa T, Waltz AG: Experimental subarachnoid hemorrhage from a middle cerebral artery: Neurologic deficits, intracranial pressures, blood pressures, and pulse rates. Stroke 8:421-426, 1977.
51. Hino A, Weir BK, Macdonald RL, Thisted RA, Kim CJ, Johns LM: Prospective, randomized, double-blind trial of BQ-123 and bosentan for prevention of vasospasm following subarachnoid hemorrhage in monkeys. J Neurosurg 83:503-509, 1995.
52. Hongo K, Kobayashi S, Kassell NF: In vitro perfusion system for the study of cerebral vasospasm, in Sano K, Takakura K, Kassell NF, Sasaki T (eds): Cerebral Vasospasm: Proceedings of the IVth International Conference on Cerebral Vasospasm. Tokyo, University of Tokyo Press, 1990, pp 203-206.
53. Hughes JT, Schianchi PM: Cerebral artery spasm: A histological study at necropsy of the blood vessels in cases of subarachnoid hemorrhage. J Neurosurg 48:515-525, 1978.
54. Inoue T, Shimizu H, Kaminuma T, Tajima M, Watabe K, Yoshimoto T: Prevention of cerebral vasospasm by calcitonin gene-related peptide slow-release tablet after subarachnoid hemorrhage in monkeys. Neurosurgery 39:984-990, 1996.
55. Iplikcioglu AC, Bayar MA, Sav A, Erbengi T: Angiotensin-converting enzyme inhibitor cilazapril prevents chronic morphologic vasospasm in rat. Surg Neurol 41:294-298, 1994.
56. Itoh S, Sasaki T, Ide K, Ishikawa K, Nishikibe M, Yano M: A novel endothelin ETA receptor antagonist, BQ-485, and its preventive effect on experimental cerebral vasospasm in dogs. Biochem Biophys Res Commun 195:969-975, 1993.
57. Jakubowski J, Bell BA, Symon L, Zawirski MB, Francis DM: A primate model of subarachnoid hemorrhage: Change in regional cerebral blood flow, autoregulation carbon dioxide reactivity, and central conduction time. Stroke 13:601-611, 1982.
58. Jakubowski J, McCleery WNC, Todd JH: Acute haemorrhagic cerebral vasospasm in the dog: An experimental model. Br J Anaesth 45:1235-1236, 1973.
59. Kaoutzanis M, Yokota M, Sibilia R, Peterson JW: Neurologic evaluation in a canine model of single and double subarachnoid hemorrhage. J Neurosci Methods 50:301-307, 1993.
60. Kapp J, Mahaley MS, Odom GL: Cerebral arterial spasm: Part I - Evaluation of experimental variables affecting the diameter of the exposed basilar artery. J Neurosurg 29:331-338, 1968.
61. Kapp J, Mahaley MS, Odom GL: Cerebral arterial spasm: Part II - Experimental evaluation of mechanical and humoral factors in pathogenesis. J Neurosurg 29:339-349, 1968.
62. Kapp J, Mahaley MS, Odom GL: Cerebral arterial spasm: Part III - Partial purification and characterization of a spasmogenic substance in feline platelets. J Neurosurg 29:350-356, 1968.
63. Kassell NF, Haley EC Jr, Apperson-Hansen C, Alves WM: Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: A cooperative study in Europe, Australia, and New Zealand. J Neurosurg 84:221-228, 1996.
64. Kistler JP, Crowell RM, Davis KR, Heros R, Ojemann RG, Zervas T, Fisher CM: The relation of cerebral vasospasm to the extent and location of subarachnoid blood visualized by CT scan: A prospective study. Neurology 33:424-436, 1983.
65. Kokubu K, Tani E, Nakano M, Minami N, Shindo H: Effects of ML-9 on experimental delayed cerebral vasospasm. J Neurosurg 71:916-922, 1989.
66. Kuwayama A, Zervas NT, Belson R, Shintani A, Pickren K: A model for experimental cerebral arterial spasm. Stroke 3:49-56, 1972.
67. Kuwayama A, Zervas NT, Shintani A, Pickren KS: Papaverine hydrochloride and experimental hemorrhagic cerebral arterial spasm. Stroke 3:27-33, 1972.
68. Landau B, Ransohoff J: Prolonged cerebral vasospasm in experimental subarachnoid hemorrhage. Neurology 18:1056-1065, 1968.
69. Liszczak TM, Black PM, Tzouras A, Foley L, Zervas NT: Morphological changes of the basilar artery, ventricles, and choroid plexus after experimental SAH. J Neurosurg 61:486-493, 1984.
70. Liszczak TM, Varsos VG, Black PM, Kistler JP, Zervas NT: Cerebral arterial constriction after experimental subarachnoid hemorrhage is associated with blood components within the arterial wall. J Neurosurg 58:18-26, 1983.
71. Logothetis J, Karacostas D, Karoutas G, Artemis N, Mansouri A, Milonas I: A new model of subarachnoid hemorrhage in experimental animals with the purpose to examine cerebral vasospasm. Exp Neurol 81:257-278, 1983.
72. Lougheed VVM, Tom M: A method of introducing blood into the subarachnoid space in the region of the circle of Willis in dogs. Can J Surg 4:329-337, 1961.
73. Macdonald RL: Cerebral vasospasm. Neurosurg Q 5:73-97, 1995.
74. Macdonald RL, Wallace MC, Montanera WJ, Glen JA: Pathological effects of angioplasty on vasospastic carotid arteries in a rabbit model. J Neurosurg 83:111-117, 1995.
75. Macdonald RL, Weir BK, Chen MH, Grace MG: Scanning electron microscopy of normal and vasospastic monkey cerebrovascular smooth muscle cells. Neurosurgery 29:544-550, 1991.
76. Macdonald RL, Weir BK, Grace MG, Martin TP, Doi M, Cook DA: Morphometric analysis of monkey cerebral arteries exposed in vivo to whole blood, oxyhemoglobin, methemoglobin, and bilirubin. Blood Vessels 28:498-510, 1991.
77. Macdonald RL, Weir BK, Runzer TD, Grace MG, Findlay JM, Saito K, Cook DA, Mielke BW, Kanamaru K: Etiology of cerebral vasospasm in primates. J Neurosurg 45:415-424, 1991.
78. Macdonald RL, Zhang J, Han H: Angioplasty reduces pharmacologically mediated vasoconstriction in rabbit carotid arteries with and without vasospasm. Stroke 26:1053-1060, 1995.
79. Macfarlane R, Teramura A, Owen CJ, Chase S, de la Torre R, Gregory KW, Peterson JW, Birngruber R, Parrish JA, Zervas NT: Treatment of vasospasm with a 480-nm pulsed-dye laser. J Neurosurg 75:613-622, 1991.
80. Mahaley MS Jr, Kapp J: The effect of isordil and cyclospasmol on vascular spasm induced in the basilar artery of the cat. Stroke 1:325-329, 1970.
81. Matsui T, Asano T: Effects of new 21-aminosteroid tirilazad mesylate (U74006F) on chronic cerebral vasospasm in a "two-hemorrhage" model of beagle dogs. Neurosurgery 34:1035-1039, 1994.
82. Mayberg M, Houser OW, Sundt TM Jr: Ultrastructural changes in feline arterial endothelium following subarachnoid hemorrhage. J Neurosurg 48:49-57, 1978.
83. Mayberg MR, Okada T, Bark DH: The role of hemoglobin in arterial narrowing after subarachnoid hemorrhage. J Neurosurg 72:634-640, 1990.
84. Mayberg MR, Okada T, Bark DH: The significance of morphological changes in cerebral arteries after subarachnoid hemorrhage. J Neurosurg 72:626-633, 1990.
85. McQueen JD, Jeanes LD: Influence of hypothermia on intracranial hypertension. J Neurosurg 19:277-288, 1962.
86. McQueen JD, Jeanes LD: Dehydration and rehydration of the brain with hypertonic urea and mannitol. J Neurosurg 21:118-128, 1964.
87. McQueen JD, Jelsma LF: Intracranial hypertension: Cerebrospinal fluid pressure rises following intracisternal infusions of blood components in dogs. Arch Neurol 16:501-508, 1967.
88. Megyesi JF, Findlay JM, Vollrath B, Cook DA, Chen MH: In vivo angioplasty prevents the development of vasospasm in canine carotid arteries: Pharmacological and morphological analyses. Stroke 28:1216-1224, 1997.
89. Megyesi JF, Vollrath B, Cook DA, Chen MH, Findlay JM: Long-term effects of in vivo angioplasty in normal and vasospastic canine carotid arteries: Pharmacological and morphological analyses. J Neurosurg 91:100-108, 1999.
90. Muizelaar JP: Angioplasty reduces pharmacologically mediated vasoconstriction in rabbit carotid arteries with and without vasospasm. Stroke 26:1059-1060, 1996 (comment).
91. Muizelaar JP, Zwienenberg M, Rudisill NA, Hecht ST: The prophylactic use of transluminal balloon angioplasty in patients with Fisher Grade 3 subarachnoid hemorrhage: A pilot study. J Neurosurg 91:51-58, 1999.
92. Nagai H, Suzuki Y, Sugiura M, Noda S, Mabe H: Experimental cerebral vasospasm: Part I - Factors contributing to early spasm. J Neurosurg 41:285-292, 1974.
93. Nakao K, Murata H, Kanamaru K, Waga S: Effects of nitroglycerin on vasospasm and cyclic nucleotides in a primate model of subarachnoid hemorrhage. Stroke 27:1882-1888, 1996.
94. Nosko M, Weir B, Krueger C, Cook D, Norris S, Overton T, Boisvert D: Nimodipine and chronic vasospasm in monkeys: Part I - Clinical and radiological findings. Neurosurgery 16:129-136, 1985.
95. Nosko M, Weir BK, Lunt A, Grace M, Allen P, Mielke B: Effect of clot removal at 24 hours on chronic vasospasm after SAH in the primate model. J Neurosurg 66:416-422, 1987.
96. Nozaki K, Okamoto S, Uemura Y, Kikuchi H, Mizuno N: Vascular relaxation properties of calcitonin gene-related peptide and vasoactive intestinal polypeptide in subarachnoid hemorrhage. J Neurosurg 72:792-797, 1990.
97. Offerhaus L, Van Gool J: Electrocardiographic changes and tissue catecholamines in experimental subarachnoid haemorrhage. Cardiovasc Res 3:433-440, 1969.
98. Ohkuma H, Parney I, Megyesi J, Ghahary A, Findlay JM: Antisense preproendothelin-oligoDNA therapy for vasospasm in a canine model of subarachnoid hemorrhage. J Neurosurg 90:1105-1114, 1999.
99. Ohta T, Tsuji M, Yamada K, Yasuda A, Mori M, Ogawa R, Tamura Y, Yoshizaki Y: Pharmacological study on cerebral vessels with or without endothelium, using a new perfusion system, in Sano K, Takakura K, Kassell NF, Sasaki T (eds): Cerebral Vasospasm: Proceedings of the IVth International Conference on Cerebral Vasospasm. Tokyo, University of Tokyo Press, 1990, pp 199-202.
100. Okada T, Harada T, Bark DH, Mayberg MR: A rat femoral artery model for vasospasm. Neurosurgery 27:349-356, 1990.
101. Onoda K, Ono S, Ogihara K, Shiota T, Asari S, Ohmoto T, Ninomiya Y: Inhibition of vascular contraction by intracisternal administration of preproendothelin-1 mRNA antisense oligoDNA in a rat experimental vasospasm model. J Neurosurg 85:846-852, 1996.
102. Onoda K, Ono S, Ogihara K, Shiota T, Asari S, Ohmoto T, Ninomiya Y: Role of extracellular matrix in experimental vasospasm: Inhibitory effect of antisense oligonucleotide on collagen induction. Stroke 27:2102-2109, 1996.
103. Ostergaard JR, Voldby B: Altered extracranial vascular reactivity in patients with cerebral arterial aneurysm: An in vitro study. Surg Neurol 15:47-50, 1980.
104. Pardes H, West A, Pincus HA: Physicians and the animal-rights movement. N Engl J Med 324:1640-1643, 1991.
105. Pennink M, White RP, Crockarell JR, Robertson JT: Role of prostaglandin F2 in the genesis of experimental cerebral vasospasm: Angiographic study in dogs. J Neurosurg 37:398-406, 1972.
106. Pickard JD, Boisvert DP, Graham DI, Fitch W: Late effects of subarachnoid haemorrhage on the response of the primate cerebral circulation to drug-induced changes in arterial blood pressure. J Neurol Neurosurg Psychiatry 42:899-903, 1979.
107. Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM, Humphrey PR, Lang DA, Nelson R, Richards P, Sinar J, Bailey S, Skene A: Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ 298:636-642, 1989.
108. Pickard JD, Walker V, Perry S, Smythe PJ, Eastwood S, Hunt R: Arterial eicosanoid production following chronic exposure to a periarterial haematoma. J Neurol Neurosurg Psychiatry 47:661-667, 1984.
109. Piepgras A, Thome C, Schmiedek P: Characterization of an anterior circulation rat subarachnoid hemorrhage model. Stroke 26:2347-2352, 1995.
110. Pluta RM, Deka-Starosta A, Zauner A, Morgan JK, Muraszako KM, Oldfield EH: Neuropeptide Y in the primate model of subarachnoid hemorrhage. J Neurosurg 77:417-423, 1992.
111. Pluta RM, Oldfield EH, Boock RJ: Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage. J Neurosurg 87:746-751, 1997.
112. Pluta RM, Zauner A, Morgan JK, Muraszko KM, Oldfield EH: Is vasospasm related to proliferative arteriopathy? J Neurosurg 77:740-748, 1992.
113. Rhodin JAG: Architecture of the vessel wall, in Bohr DF, Somlyo AP, Sparks HV (eds): Handbook of Physiology. Philadelphia, W.B. Saunders Co., 1980, vol 2, pp 1-31.
114. Ritchie WL, Weir B, Overton TR: Experimental subarachnoid hemorrhage in the cynomolgus monkey: Evaluation of treatment with hypertension, volume expansion, and ventilation. Neurosurgery 6:57-62, 1980.
115. Shiokawa K, Kasuya H, Miyajima M, Izawa M, Takakura K: Prophylactic effect of papaverine prolonged-release pellets on cerebral vasospasm in dogs. Neurosurgery 42:109-116, 1998.
116. Simeone FA, Vinall PE: Evaluation of animal models of cerebral vasospasm, in Wilkins RH (ed): Cerebral Arterial Spasm: Proceedings of the Second International Workshop. Baltimore, Williams & Wilkins, 1980, pp 284-286.
117. Simeone FA, Ryan KG, Cotter JR: Prolonged experimental cerebral vasospasm. J Neurosurg 29:357-366, 1968.
118. Simeone FA, Trepper PJ, Brown DJ: Cerebral blood flow evaluation of prolonged experimental vasospasm. J Neurosurg 37: 302-311, 1972.
119. Smith RR: A rat femoral artery model for vasospasm. Neurosurgery 27:356, 1990 (comment).
120. Smith SJ, Hendee WR: Animals in research. JAMA 259:2007-2008, 1988.
121. Smith RR, Clower BR, Grotendorst GM, Yabuno N, Cruse JM: Arterial wall changes in early human vasospasm. Neurosurgery 16:171-176, 1985.
122. Solomon RA, Antunes JL, Chen RY, Bland L, Chien S: Decrease in cerebral blood flow in rats after experimental subarachnoid hemorrhage: A new animal model. Stroke 16:58-64, 1985.
123. Steiner L, Lofgren J, Zwetnow NN: Characteristics and limits of tolerance in repeated subarachnoid hemorrhage in dogs. Acta Neurol Scand 52:241-267, 1975.
124. Steinke DE, Weir BK, Findlay JM, Tanabe T, Grace M, Krushelnycky BW: A trial of the 21-aminosteroid U74006F in a primate model of chronic cerebral vasospasm. Neurosurgery 24:179-186, 1989.
125. Strickberger MW: Evolution. Boston, Jones and Bartlett Publishers, 1996, ed 2, pp 417-480.
126. Takahashi S, Kassell NF, Toshima M, Dougherty DA, Foley PL, Lee KS: Effect of U88999E on experimental cerebral vasospasm in rabbits. Neurosurgery 32:281-288, 1993.
127. Takayasu M, Suzuki Y, Shibuya M, Asano T, Kanamori M, Okada T, Kageyama N, Hidaka H: The effects of HA compound calcium antagonists on delayed cerebral vasospasm in dogs. J Neurosurg 65:80-85, 1986.
128. Takemae T, Branson I, Alksne JF: Intimal proliferation of cerebral arteries after subarachnoid blood injection in pigs. J Neurosurg 61:494-500, 1984.
129. Teramura A, Macfarlane R, Owen CJ, de la Torre R, Gregory KW, Birngruber R, Parrish JA, Peterson JW, Zervas NT: Application of the 1-microsecond pulsed-dye laser to the treatment of experimental cerebral vasospasm. J Neurosurg 75:271-276, 1991.
130. Toda N, Kawakami M, Yoshida K: Constrictor action of oxyhemoglobin in monkey and dog basilar arteries in vivo and in vitro. Am J Physiol 260:H420-H425, 1991.
131. Trojanowski T: Experimental subarachnoid haemorrhage: Part I - A new approach to subarachnoid blood injection in cats. Acta Neurochir (Wien) 62:171-175, 1982.
132. Vanhoutte PM, Katusic ZS, Shepherd JT: Vasopressin induces endothelium-dependent relaxations of cerebral and coronary, but not of systemic arteries. J Hypertens 2(Suppl 3):S421-S422, 1984.
133. Varsos VG, Liszczak TM, Han DH, Kistler JP, Vielma J, Black PMcL, Heros RC, Zervas NT: Delayed cerebral vasospasm is not reversible by aminophylline, nifedipine, or papaverine in a "two-hemorrhage" canine model. J Neurosurg 58:11-17, 1983.
134. Veelken JA, Laing RJC, Jakubowski J: The Sheffield model of subarachnoid hemorrhage in rats. Stroke 26:1279-1284, 1995.
135. Weir B, Erasmo R, Miller J, McIntyre J, Secord D, Mielke B: Vasospasm in response to repeated subarachnoid hemorrhages in the monkey. J Neurosurg 33:395-406, 1970.
136. Weir B, Grace M, Hansen J, Rothberg C: Time course of vasospasm in man. J Neurosurg 48:173-178, 1978.
137. Wilkins RH, Levitt P: Intracranial arterial spasm in the dog: A chronic experimental model. J Neurosurg 33:260-269, 1970.
138. Yamaguchi T, Waltz AG: Effects of subarachnoid hemorrhage from puncture of the middle cerebral artery on blood flow and vasculature of the cerebral cortex in the cat. J Neurosurg 35:664-671, 1971.
139. Yamaura I, Tani E, Maeda Y, Minami N, Shindo H: Endothelin-1 of canine basilar artery in vasospasm. J Neurosurg 76:99-105, 1992.
140. Zabramski JM, Spetzler RF, Bonstelle C: Chronic cerebral vasospasm: Effect of volume and timing of hemorrhage in a canine model. Neurosurgery 18:1-6, 1986.
141. Zuccarello M, Lewis AI, Upputuri S, Farmer JB, Anderson DK: Effect of remacemide hydrochloride on subarachnoid hemorrhage-induced vasospasm in rabbits. J Neurotrauma 11:691-698, 1994.